Evidence map›Paper›PMID 30987108›Full record

ArticleInternational journal of molecular sciences2019

Hyaluronic Acid Combined with Serum Rich in Growth Factors in Corneal Epithelial Defects.

Carlota Suárez-Barrio, Jaime Etxebarria, Raquel Hernáez-Moya, Marina Del Val-Alonso, Maddalen Rodriguez-Astigarraga, Arantza Urkaregi, Vanesa Freire, María-Celia Morales, Juan Antonio Durán, Marta Vicario and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Elevated Opioid Growth Factor Alters the Limbus in Type 1 Diabetic Rats.Journal of diabetes and clinical research · 2023
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Blood-Derived Products for Tissue Repair/Regeneration.International journal of molecular sciences · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Carlota Suárez-BarrioDepartment of Cell Biology and Histology, School of Medicine and Nursing, University of the Basque Country, BioCruces Health Research Institute, Begiker, 48940 Leioa, Spain. carlotasb.8@gmail.com.ORCID 0000-0003-0171-1851
Jaime EtxebarriaDepartment of Cell Biology and Histology, School of Medicine and Nursing, University of the Basque Country, BioCruces Health Research Institute, Begiker, 48940 Leioa, Spain. JAIME.ECHEVARRIAECENARRO@osakidetza.eus.
Raquel Hernáez-MoyaDepartment of Cell Biology and Histology, School of Medicine and Nursing, University of the Basque Country, BioCruces Health Research Institute, Begiker, 48940 Leioa, Spain. raquel.hernaez@ehu.eus.ORCID 0000-0002-8684-8306
Marina Del Val-AlonsoDepartment of Cell Biology and Histology, School of Medicine and Nursing, University of the Basque Country, BioCruces Health Research Institute, Begiker, 48940 Leioa, Spain. marina_mdv@hotmail.com.
Maddalen Rodriguez-AstigarragaDepartment of Cell Biology and Histology, School of Medicine and Nursing, University of the Basque Country, BioCruces Health Research Institute, Begiker, 48940 Leioa, Spain. m.rodriguezastigarraga@gmail.com.
Arantza UrkaregiDepartment of Applied Mathematics and Statistics and Operational Research, BioCruces Health Research Institute, 48940 Leioa, Spain. arantza.urkaregi@ehu.eus.
Vanesa FreireDepartment of Cell Biology and Histology, School of Medicine and Nursing, University of the Basque Country, BioCruces Health Research Institute, Begiker, 48940 Leioa, Spain. vanesafreire@hotmail.com.
María-Celia MoralesDepartment of Cell Biology and Histology, School of Medicine and Nursing, University of the Basque Country, BioCruces Health Research Institute, Begiker, 48940 Leioa, Spain. celiamoralesgonzalez@gmail.com.
Juan Antonio DuránR & D Department, Instituto Clínico-Quirúrgico de Oftalmología, 48006 Bilbao, Spain. duran@icqo.org.
Marta VicarioPharmaceutical Innovation in Ophthalmology (InnOftal) UCM Research Group 920415. Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University, 28040 Madrid, Spain. mvicario@farm.ucm.es.
Irene MolinaPharmaceutical Innovation in Ophthalmology (InnOftal) UCM Research Group 920415. Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University, 28040 Madrid, Spain. iremm@farm.ucm.es.ORCID 0000-0002-9157-571X
Rocío Herrero-VanrellPharmaceutical Innovation in Ophthalmology (InnOftal) UCM Research Group 920415. Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University, 28040 Madrid, Spain. rociohv@farm.ucm.es.ORCID 0000-0001-9764-7975
Noelia AndolloDepartment of Cell Biology and Histology, School of Medicine and Nursing, University of the Basque Country, BioCruces Health Research Institute, Begiker, 48940 Leioa, Spain. noelia.andollo@ehu.eus.ORCID 0000-0002-8918-6395
University of the Basque Country · ESBioCruces Health research Institute · ES

Funding

Euskal Herriko Unibertsitatea US16/23Eusko Jaurlaritza BIO14/TP/002
6 · The paper itself

Abstract

The aim of this study is to assess if an adhesive biopolymer, sodium hyaluronate (NaHA), has synergistic effects with s-PRGF (a serum derived from plasma rich in growth factors and a blood derivative that has already shown efficacy in corneal epithelial wound healing), to reduce time of healing or posology. In vitro proliferation and migration studies, both in human corneal epithelial (HCE) cells and in rabbit primary corneal epithelial (RPCE) cultures, were carried out. In addition, we performed studies of corneal wound healing in vivo in rabbits treated with s-PRGF, NaHA, or the combination of both. We performed immunohistochemistry techniques (CK3, CK15, Ki67, ß4 integrin, ZO-1, α-SMA) in rabbit corneas 7 and 30 days after a surgically induced epithelial defect. In vitro results show that the combination of NaHA and s-PRGF offers the worst proliferation rates in both HCE and RPCE cells. Addition of NaHA to s-PRGF diminishes the re-epithelializing capability of s-PRGF. In vivo, all treatments, given twice a day, showed equivalent efficacy in corneal epithelial healing. We conclude that the combined use of s-PRGF and HaNA as an adhesive biopolymer does not improve the efficacy of s-PRGF alone in the wound healing of corneal epithelial defects.

Indexed as

AnimalsCell AdhesionCell DifferentiationCell ProliferationCells, CulturedCell SurvivalDisease Models, AnimalEpithelial CellsEpithelium, CornealFibrosisHumansHyaluronic AcidIntegrin beta4Intercellular Signaling Peptides and ProteinsKi-67 AntigenRabbitsHyaluronic AcidIntegrin beta4Intercellular Signaling Peptides and ProteinsKi-67 AntigenZonula Occludens-1 Proteincorneal epithelial defectcornea regenerationhyaluronic acid (NaHA)plasma rich plasma (PRP)serum derived from plasma rich in growth factors (s-PRGF)serum eye dropswound healing

Identifiers

PMID30987108
PMCPMC6480555
OpenAlexW2933641408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.